Clinical Trial to Evaluate the Pharmacokinetics and Safety Between the Single Administration of HL1113 and the Concomitant Administration of HL1113R1 and HL1113R2 for Healthy Subjects in Fasting State
Clinical trial NCT07568652 · COMPLETED
Trial details
- NCT number
- NCT07568652
- Sponsor
- Hanlim Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-16
- Primary completion
- 2024-11-15
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.